Your browser doesn't support javascript.
loading
Prolonged Gut Dysbiosis and Fecal Excretion of Hepatitis A Virus in Patients Infected with Human Immunodeficiency Virus.
Ishizaka, Aya; Koga, Michiko; Mizutani, Taketoshi; Lim, Lay Ahyoung; Adachi, Eisuke; Ikeuchi, Kazuhiko; Ueda, Ryuta; Aoyagi, Haruyo; Tanaka, Satoshi; Kiyono, Hiroshi; Matano, Tetsuro; Aizaki, Hideki; Yoshio, Sachiyo; Mita, Eiji; Muramatsu, Masamichi; Kanto, Tatsuya; Tsutsumi, Takeya; Yotsuyanagi, Hiroshi.
Afiliação
  • Ishizaka A; Division of Infectious Diseases, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
  • Koga M; International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
  • Mizutani T; Japan Foundation for AIDS Prevention, Tokyo 101-0064, Japan.
  • Lim LA; Division of Infectious Diseases, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
  • Adachi E; Division of Infectious Diseases, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
  • Ikeuchi K; International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
  • Ueda R; Department of Infectious Diseases and Applied Immunology, IMSUT Hospital of Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
  • Aoyagi H; Department of Infectious Diseases and Applied Immunology, IMSUT Hospital of Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
  • Tanaka S; Department of Infectious Diseases and Applied Immunology, IMSUT Hospital of Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
  • Kiyono H; Department of Virology II, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Matano T; Department of Virology II, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Aizaki H; Department of Gastroenterology and Hepatology, National Hospital Organization Osaka National Hospital, Osaka 540-0006, Japan.
  • Yoshio S; International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
  • Mita E; CU-UCSD Center for Mucosal Immunology, Allergy and Vaccines (cMAV), Department of Medicine, University of California San Diego, San Diego, CA 92093, USA.
  • Muramatsu M; AIDS Research Center, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Kanto T; Department of AIDS Vaccine Development, IMSUT Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
  • Tsutsumi T; Department of Virology II, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Yotsuyanagi H; The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba 272-8516, Japan.
Viruses ; 13(10)2021 10 18.
Article em En | MEDLINE | ID: mdl-34696531
Hepatitis A virus (HAV) causes transient acute infection, and little is known of viral shedding via the duodenum and into the intestinal environment, including the gut microbiome, from the period of infection until after the recovery of symptoms. Therefore, in this study, we aimed to comprehensively observe the amount of virus excreted into the intestinal tract, the changes in the intestinal microbiome, and the level of inflammation during the healing process. We used blood and stool specimens from patients with human immunodeficiency virus who were infected with HAV during the HAV outbreak in Japan in 2018. Moreover, we observed changes in fecal HAV RNA and quantified the plasma cytokine level and gut microbiome by 16S rRNA analysis from clinical onset to at least 6 months after healing. HAV was detected from clinical onset up to a period of more than 150 days. Immediately after infection, many pro-inflammatory cytokines were elicited, and some cytokines showed different behaviors. The intestinal microbiome changed significantly after infection (dysbiosis), and the dysbiosis continued for a long time after healing. These observations suggest that the immunocompromised state is associated with prolonged viral shedding into the intestinal tract and delayed recovery of the intestinal environment.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fezes / Disbiose / Hepatite A Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fezes / Disbiose / Hepatite A Idioma: En Ano de publicação: 2021 Tipo de documento: Article